EMA
approval
· 2012-09-21
European Medicines Agency recommends authorisation of first medicine specifically for irritable bowel syndrome
Summary
The EMA recommends authorisation of the first medicine specifically for irritable bowel syndrome, marking a milestone for IBS treatment options.
Upgrade for the full analysis, importance score, and drug timeline.